[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
The role of reinfection and the importance of partner treatment were added to a pharmacoeconomic model for the analysis of a GP-based opportunistic screening programme for Chlamydia trachomatis (CT) in sexually active women in Amsterdam. A favourable cost-effectiveness was found for partner treatment. Partner treatment was cost saving and overall net costs per major outcome averted by the screening programme were reduced by 40% or more due to partner treatment. From a pharmacoeconomic point of view partner treatment should be routinely provided in the framework of a CT screening programme for Amsterdam women.
Postma
M J
MJ
Groningen University Institute for Drug Exploration (GUIDE)/Rijksuniversiteit, vakgroep Sociale Farmacie en Farmaco-epidemiologie. m.postma@farm.rug.nl
Welte
R
R
van den Hoek
J A
JA
Jager
J C
JC
van Doornum
G J
GJ
Coutinho
R A
RA
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D002692:Chlamydia trachomatis; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D009426:Netherlands / Q000453:epidemiology; D011159:Population Surveillance; D055502:Secondary Prevention; D012747:Sexual Partners
D000900:Anti-Bacterial Agents
Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking in Amsterdam. III. Kosteneffectiviteitsanalyse van screening bij vrouwen uitgebreid met de rol van herinfectie en partnermeebehandeling.